Can i ask what good interim results are we looking for that will give the FDA reasons for stopping the trial earlier than the expected finish date of June 2018. Will it be based on primary outcome measures, secondary outcome measures or both. https://clinicaltrials.gov/ct2/show/record/NCT02032004
$5.8 Billion, page-16
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.06 |
Change
0.000(0.00%) |
Mkt cap ! $1.210B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 9960 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 5000 | 1 |
View Market Depth
| Last trade - 10.01am 03/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
Day chart unavailable